Try our beta test site

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

This study has been completed.
Sponsor:
Collaborator:
Immune Tolerance Network (ITN)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00078195
First received: February 19, 2004
Last updated: October 14, 2016
Last verified: October 2016